Second, an Asyn imaging agent must have more than 10 fold selectivity for Asyn fibrils over Aβ and tau fibrils, since many cases of PD have widespread accumulation of Aβ and rare cases have widespread accumulation of tau [9,13,14,15,16]. This evidence concerns the gene MAPT and Parkinson disease.